In general, most studies support the view that TWEAK/Fn14 signaling in the tumor microenvironment will most likely stimulate pro-tumorigenic/metastatic cellular responses, including tumor cell growth (88, 108), invasion (8, 10, 18–20), and resistance to chemotherapeutic agents (109). This evidence concerns the gene TNFRSF12A and neoplasm.